GRAL vs ADPT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ADPT Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adaptive Biotechnologies Corporation Common Stock (ADPT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while GRAL counters with relative strength in Valuation. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus ADPT at N/M Forward P/E and -16.2% operating margin (-10.7% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against ADPT sits in CONSOLIDATION (36th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | GRAL Revenue | ADPT Revenue | GRAL Op. Margin | ADPT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $60M | N/A | -89.4% | ADPT |
| FY2019 | N/A | $90M | N/A | -92.1% | ADPT |
| FY2020 | N/A | $100M | N/A | -155.3% | ADPT |
| FY2021 | N/A | $150M | N/A | -135.4% | ADPT |
| FY2022 | N/A | $190M | N/A | -108.0% | ADPT |
| FY2023 | $90M | $170M | -1627.6% | -133.3% | ADPT |
| FY2024 | $130M | $180M | -1743.0% | -90.8% | ADPT |
| FY2025 | $150M | $280M | -382.0% | -20.6% | ADPT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GRAL | ADPT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.2B | $4.7B | Larger Scale | GRAL |
| Trailing P/E Ratio Valuation | 1.1x | N/M | Lower Multiple | GRAL |
| Forward P/E Ratio Valuation | 1.1x | N/M | Lower Multiple | GRAL |
| Revenue Growth (YoY) Growth | +3.7% | -10.7% | Higher Growth | GRAL |
| Operating Margin (TTM) Profitability | -332.0% | -16.2% | Higher Margin | ADPT |
| Net Profit Margin Profitability | -243.8% | -23.7% | Higher Margin | ADPT |
| Return on Equity (ROE) Capital Efficiency | -17.3% | -36.4% | Higher ROE | GRAL |
| 52-Week Range Position Momentum | 51% ($42โ$166) | 78% ($12โ$32) | Stronger Trend | ADPT |
| Beta / 30D Volatility Risk Regime | 3.09ฮฒ ยท 99% Vol | 1.74ฮฒ ยท 60% Vol | Lower Realized Risk | ADPT |
| Unified Institutional Score Composite Signal | 54.5 / 100 (HOLD) | 43.8 / 100 (HOLD) | Higher Composite | GRAL |